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We isolated Burkholderia pseudomallei, the causative 
agent of melioidosis, from liver granulomas of a pet green 
iguana (Iguana iguana) in Belgium. This case highlights 
a risk for imported green iguanas acting as a reservoir 
for introduction of this high-threat, zoonotic pathogen into 
nonendemic regions.
The highly pathogenic, gram-negative bacterium Burk-holderia pseudomallei is the causative agent of melioi-
dosis, which is endemic to countries in Southeast Asia and in 
northern Australia and an emerging infectious disease in sev-
eral tropical developing countries (1,2). Human cases in Eu-
rope are limited to patients who traveled to disease-endemic 
regions. In Belgium, the last case was documented in 2013 
in a 44-year-old man who had traveled to Madagascar (3). 
B. pseudomallei is classified as a tier 1 overlap select agent 
by the US Federal Select Agent Program (4). Postexposure 
prophylaxis and postexposure monitoring should be planned 
for persons who have had high-risk exposures, such as cer-
tain laboratory procedures with the organism that were not 
conducted under Biosafety Level 3 conditions (5).
Infected humans and importing of infected animals can 
introduce melioidosis into nonendemic areas (2,6). Howev-
er, importing of infected animals has not yet been associat-
ed with epizootic transmission. Infection commonly occurs 
through cutaneous inoculation, ingestion of contaminated 
soil or water, or inhalation of aerosolized bacteria (7,8). Al-
though the incubation period in humans is typically 1–21 
days, clinical disease might develop years after infection 
(9). The incubation period in naturally infected animals is 
not known (10).
Acute melioidosis results predominantly in pneumo-
nia and septicemia. Chronic infection is associated with 
abscesses of the liver, lungs, spleen, and skin (9). Because 
of the intrinsic resistance of the bacterium to many anti-
microbial drugs, combined with the inability to provide 
appropriate medical care in disease-endemic developing 
countries, overall case-fatality rates might exceed 70% 
(1,4,9). B. pseudomallei is rarely reported in animals other 
than cattle, goats, and swine (10).
In reptiles, isolation of B. pseudomallei has been anec-
dotally documented in crocodiles (10), and clinical infec-
tions have been reported in 2 pet green iguanas in Cali-
fornia, USA (11) and a pet green iguana in Prague (Czech 
Republic) (4). Dermal abscesses were observed in the igua-
na from the Czech Republic and in 1 of the iguanas from 
California, and hepatic masses were observed in the second 
iguana from California.
Because of the variable clinical manifestations of 
melioidosis and limited value of conventional bacterial 
methods for identification of B. pseudomallei, diagnosis of 
melioidosis can be challenging (2,11). If one considers the 
highly pathogenic and zoonotic nature of B. pseudomallei, 
use of appropriate molecular detection methods is crucial 
to warrant correct identification and discrimination of B. 
pseudomallei from other Burkholderia species (11). Next-
generation sequencing might be a valuable supplement to 
current identification and diagnostic methods.
The Study
A 5-year-old female green iguana (Iguana iguana) showed 
acute onset of lethargy, anorexia, and general weakness. 
The iguana had been purchased 4.5 years earlier by private 
owners from a pet shop in the Netherlands that imported 
the iguana from a captive breeding operation in Central 
America. Serum biochemical and hematologic tests showed 
hyperuricemia, hyperphosphatemia, an increased level of 
aspartate aminotransferase, hyperglobulinemia, nonregen-
erative anemia, and severe leukocytosis in comparison 
with physiologic reference ranges for these conditions (12). 
Ultrasonography showed hepatomegaly, multiple hyper-
echoic hepatic masses, and severely enlarged, hyperechoic 
kidneys. A presumptive diagnosis of hepatitis, kidney fail-
ure, and septicemia was made. Because the iguana did not 
respond to supportive treatment and its general condition 
continued to deteriorate, the owners agreed to euthanize the 
iguana on the fifth day after signs began.
During necropsy, pronounced renomegaly and hepato-
megaly, as well as granulomatous hepatitis was observed. 
Histologic evaluation of hematoxylin and eosin–stained 
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sections of liver showed coalescent granulomas throughout 
the liver parenchyma, with central necrosis surrounded by ac-
tivated macrophages and giant cells (Figure). Gram, periodic 
acid–Schiff, and acid-fast staining did not show intralesional 
gram-positive or acid-fast bacteria or fungi. Microbiological 
examination of liver tissue yielded a pure and abundant cul-
ture of small colonies of gram-negative rods that could not be 
identified by using standard biochemical identification tests.
Sequencing of the 16S rRNA gene of the isolate 
showed 100% identity with B. pseudomallei (1,382 bp). 
Sequence data were deposited in GenBank under acces-
sion no. MF523223. After culturing of the isolate under 
Biosafety Level 3 conditions, we performed multilocus 
sequence typing–derived PCR and real-time PCR as de-
scribed by Wattiau et al. (13), which confirmed identifica-
tion of the isolate as B. pseudomallei.
We used next-generation sequencing to obtain the ge-
nome sequence of the isolate, which was deposited in the 
Short Read Archive under accession no. SRR6056996. 
The genome sequence was used to infer its multilocus se-
quence type (ST) as ST518. Isolate information was depos-
ited accordingly in the B. pseudomallei database (https://
pubMLST.org) under ID 5121 (14). Of 5,600 deposited 
isolates that we accessed on June 18, 2018, ST518 matched 
only with B. pseudomallei isolates (ID 3330) obtained from 
a human who was infected in Costa Rica in 2009 (ID 1928) 
(14) and with 2 isolates obtained from abscesses in pet igua-
nas in 2007 (ID 5008) and 2012 (ID 3330) (11). We found 
that ID 3330 differed from the isolates from Central Amer-
ica by only 3 single-nucleotide polymorphisms, which 
strongly suggested that the iguanas were infected in Central 
America before transport abroad (15). However, whether 
captive iguanas might acquire infections through contact 
with other imported animals (e.g., in pet shops or in captive 
collections in nonendemic countries) cannot be excluded.
After we identified the isolate as B. pseudomallei, we 
collected 100 mL of water from a plastic water bath and a 
swab specimen from the emptied water reservoir from the 
housing of the iguana and tested these samples by using 
real-time PCR. All samples showed negative results.
The zoonotic potential of the bacterium was dis-
cussed with the owners and personnel who came into con-
tact with the iguana or samples that were collected from 
the lizard. Although the owners did not have a clinical 
history that could indicate B. pseudomallei infection, they 
were advised to consult with their physicians about poten-
tial exposure. Although the owners refused postexposure 
prophylaxis and postexposure monitoring, postexposure 
prophylaxis was given to a selected number of staff mem-
bers as recommended by Lipsitz et al. (5) because of po-
tential exposure to the pathogen.
Conclusions
Previously reported B. pseudomallei–infected iguanas (4,11) 
and the 1 reported in this study were presumably imported 
from disease-endemic regions, highlighting the potential 
role of this species as a reservoir of B. pseudomallei. On the 
basis of the relatedness of ST518 with an isolate obtained 
from a human in Costa Rica (14) and with 2 isolates from 
iguanas that presumably became infected in Central America 
(11), whose genomes were later confirmed to be closely re-
lated (15), our findings support the hypothesis that the iguana 
we report became infected in the captive breeding facility in 
Central America before importation to Europe.
If one considers the long incubation period observed 
for green iguanas, these reptiles might shed the bacterium 
unnoticed for years before nonspecific chronic disease 
develops. Transmission from infected captive iguanas to 
humans might occur through contact with stool, infected 
tissue, or biting and scratching lesions. Indirect infection 
might originate from wound infection through contaminat-
ed soil or water or inhalation of aerosolized bacteria.
In conclusion, traders, (para)veterinarians, and labora-
tory staff members who handle green iguanas or samples 
obtained from this species are susceptible to infection. In 
addition, physicians who are consulted by pet green iguana 
owners should be aware that these animals and their envi-
ronment could potentially harbor B. pseudomallei.
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Figure. Coalescent granuloma in liver parenchyma of a pet green 
iguana (Iguana iguana) infected with Burkholderia pseudomallei, 
Belgium. Hematoxylin and eosin stain shows central necrosis 
surrounded by activated macrophages and giant cells. Scale bar 
indicates 200 µm.
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